-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target

Benzinga·07/01/2025 11:37:22
Listen to the news
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $30 price target.